Development of Itraconazole Loaded Transethosomes for improved transdermal delivery
Objective: The objective of the present work was to develop, optimize and characterize itraconazole loaded transethosomes for enhanced transdermal delivery. In this study, screening of formulation and process variables was conducted by using Box-Behnken design approach to observe significant and insignificant influence on the transethosomes. Methods: The transethosomes was developed by homogenization technique (hot method). The optimized itraconazole loaded transethosomes were evaluated for its vesicle size, polydispersity index, zeta potential, loading capacity and entrapment efficiency. Characterization was done by P-XRD, DSC and TEM. Further, in-vitro drug release study, stability study and confocal laser scanning microscopy (CLSM) study were also performed. Results: The itraconazole loaded transethosomes are developed by using soya lecithin as phospholipid, oleic acid as edge activator and cholesterol as stabilizer. Developed transethosomes showed acceptable desired vesicle size (207-409 nm), excellent colloidal dispersion characteristics (polydispersity index- 0.131 to 0.312, zeta potential -16.12to -21.96 mV) and high drug entrapment (63.37-73.02%). P-XRD and DSC results suggested that itraconazole encapsulated in amorphous state within transethosomes. In-vitro drug release study show prolonged release of itraconazole for 24 hr and confocal laser scanning microscopy confirmed accumulation of transethosomes in deeper layers of the skin. Results of stability studies showed optimized transethosomes are more stable in refrigerated temperature (4°C) as compared to room temperature (25°C). Conclusion: The results suggested that transethosomes could be better alternative to deliver drugs across the skin and potential carrier for efficient transdermal drug delivery.